Cardialen, Inc

Biopharma Acquisitions Biopharma merger and acquisition value for the fourth quarter of 2022 reached $35.7bn from 41 transactions, 21 of which had disclosed values. Making up 78% of the Q4 total was A

Cardialen Inc. 212 Third Avenue North Suite 352 Minneapolis, MN 55401 Phone: +1 (612) 963-0783 Web Site: www.cardialen.com Contact: Paula Skjefte, CEO Industry Segment: Cardiovascular Device

Cardialen Inc. 212 Third Avenue North Suite 352 Minneapolis, MN 55401 Phone: +1 (612) 963-0783 Web Site: www.cardialen.com Contact: Paula Skjefte, CEO Industry Segment: Cardiovascular Device

Start-Ups Across Health Care Ventral hernia repair is associated with a relatively high incidence of microbial contamination of the surgical site, ranging from 8% to 40%. To combat infection, [Ariste